Using two medications to prevent postpartum hemorrhage

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of administering two uterotonic agents, misoprostol and oxytocin, simultaneously compared to the standard single-agent regimen of oxytocin alone in preventing early postpartum hemorrhage. The research will involve women aged 18 and older who are admitted for delivery at Stony Brook University Hospital. The study will also assess any potential side effects associated with the dual medication approach. By comparing the outcomes of both regimens, the study seeks to provide insights into the best practices for managing postpartum hemorrhage.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- All women 18 years and older admitted to delivery at Stony Brook University hospital who agree to participate in the study

Exclusion Criteria:

* Women under 18 years old
* Women with known coagulation disorders
* Women with planned cesarean hysterectomy
* Women with known placental accreta spectrum disorders
* Women with known allergy to prostaglandins

Where it's running

• Stony Brook University
  Stony Brook, New York, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term outcomes after vacuum-induced tamponade for postpartum hemorrhage

  This study will look at women who had postpartum hemorrhage treated with vacuum-induced tamponade at a Zurich hospital to see how they fared over time, including future pregnancies and fertility.

  Recruiting University of Zurich · Zurich, Canton of Zurich · NCT07885072

• Calcium Gluconate After Birth to Reduce Blood Loss in Vaginal Delivery

  This study tests whether giving calcium gluconate right after the baby is born can help reduce blood loss for people having a vaginal delivery.

  Recruiting Rambam Health Care Campus · Haifa · NCT07714902

• Carbetocin Alone vs Carbetocin Plus Oxytocin After Elective Cesarean Delivery

  This study tests whether giving carbetocin by itself after an elective cesarean is just as good as adding a supplemental oxytocin infusion.

  Recruiting Phase 4 Mansoura University · Buraidah, Al-Qassim Region · NCT07636421

• Simulation-based postpartum hemorrhage training to boost anesthesiology team performance

  Senior anesthesiology residents will try a high-fidelity simulation program for postpartum hemorrhage to see if it improves how their teams perform during obstetric emergencies.

  Recruiting Hacettepe University · Ankara, Ankara · NCT07519252

• Carbetocin to prevent heavy bleeding after twin birth

  This trial tests whether a single dose of carbetocin given after the second twin is born reduces heavy bleeding compared with standard oxytocin in people delivering twins.

  Recruiting Phase 4 Sheba Medical Center · Ramat Gan · NCT07401524

• Draining the umbilical cord after birth to lower postpartum bleeding

  This trial tests whether draining blood from the cut umbilical cord right after birth lowers heavy bleeding after delivery in women having a term vaginal birth.

  Recruiting at 2 sites Universidad Nacional Autonoma de Honduras · Tegucigalpa, Francisco Morazán Department and 1 other locations · NCT07401160

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.